BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/29/2014 7:34:00 PM | Browse: 1603 | Download: 1833
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Adjuvant therapy in pancreatic cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Owain Peris Jones, James Daniel Melling and Paula Ghaneh |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Paula Ghaneh, Professor, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, 5th Floor UCD Building, Daulby Street, Liverpool L69 3GA, United Kingdom. p.ghaneh@liverpool.ac.uk |
| Key Words |
Pancreatic cancer; Adjuvant; Gemcitabine; Chemotherapy; Chemoradiotherapy; Phase Ⅲ |
| Core Tip |
This paper discusses every major trial undertaken in the field of adjuvant therapy in pancreatic cancer. The evolution of chemotherapeutic regimes over the past 25 years and the controversy surrounding chemoradiation are analysed, in addition to looking at the phase Ⅲ trials currently in progress. |
| Publish Date |
2014-10-29 19:34 |
| Citation |
Jones OP, Melling JD, Ghaneh P. Adjuvant therapy in pancreatic cancer. World J Gastroenterol 2014; 20(40): 14733-14746
|
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i40/14733.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i40.14733 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.